0000950123-24-008225.txt : 20240813 0000950123-24-008225.hdr.sgml : 20240813 20240813163630 ACCESSION NUMBER: 0000950123-24-008225 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240813 DATE AS OF CHANGE: 20240813 EFFECTIVENESS DATE: 20240813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SR ONE CAPITAL MANAGEMENT, LP CENTRAL INDEX KEY: 0001910264 ORGANIZATION NAME: IRS NUMBER: 843397640 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-21964 FILM NUMBER: 241202289 BUSINESS ADDRESS: STREET 1: 985 OLD EAGLE SCHOOL ROAD STREET 2: SUITE 511 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: (610) 766-2240 MAIL ADDRESS: STREET 1: 985 OLD EAGLE SCHOOL ROAD STREET 2: SUITE 511 CITY: WAYNE STATE: PA ZIP: 19087 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001910264 XXXXXXXX 06-30-2024 06-30-2024 false SR One Capital Management, LP
985 Old Eagle School Road Suite 511 Wayne PA 19087
13F HOLDINGS REPORT 028-21964 000306361 801-119142 N
Sasha Keough General Counsel and CCO (410) 800-7503 /s/ Sasha Keough Timonium MD 08-13-2024 0 9 319401842 false
INFORMATION TABLE 2 34916.xml INFORMATION TABLE FOR FORM 13F Alumis Inc. Common Stock 022307102 26066617 1959896 SH SOLE 1959896 0 0 Arcellx, Inc. Common Stock 03940C100 129510510 2346630 SH SOLE 2346630 0 0 ARS Pharmaceuticals, Inc. Common Stock 82835W108 34149805 4012903 SH SOLE 4012903 0 0 CRISPR Therapeutics AG Common Shares H17182108 56653844 1048951 SH SOLE 1048951 0 0 Design Therapeutics, Inc. Common Stock 25056L103 21863695 6526476 SH SOLE 6526476 0 0 enGene Holdings Inc. Common Shares 29286M105 4715000 500000 SH SOLE 500000 0 0 KALA Bio, Inc. Common Stock 483119202 3145556 443661 SH SOLE 443661 0 0 Mineralys Therapeutics Inc. Common Stock 603170101 23596817 2016822 SH SOLE 2016822 0 0 Nkarta, Inc. Common Stock 65487U108 19699998 3333333 SH SOLE 3333333 0 0